Appropriate medical treatment & supervision should be readily available in case of anaphylactic event following vaccination. Not to be administered SC, intravascularly or intradermally. Postpone vaccination in individuals suffering from acute severe febrile illness. Possible syncope & other anxiety-related reactions following or even before vaccination as psychogenic response to needle inj; place procedures to prevent falling or injury. Individuals w/ thrombocytopenia or any coagulation disorder. No protection against any other
Neisseria meningitidis groups; may not protect all vaccine recipients. Individuals at high risk for MenA infection who received MenC-CRM vaccine in their 1st yr of life. Adequate immune response may not be elicited in patients receiving immunosuppressive treatment or those w/ immunodeficiency. Not a substitute for routine tetanus immunisation. Contains Na <1 mmol/dose. Some adverse effects may temporarily affect ability to drive or use machines. Pregnancy & lactation. Paed <12 mth.
Sign Out
